Understanding HIV Latency: the Road to an HIV Cure

Overview

Journal Annu Rev Med

Publisher Annual Reviews

Specialty General Medicine

Date 2015 Jan 15

PMID 25587657

Citations 121

Authors

Matthew S Dahabieh

Emilie Battivelli

Eric Verdin

Affiliations

Soon will be listed here.

Abstract

Treatment with antiretroviral therapy dramatically increases the survival of HIV-infected individuals. However, treatment has to be continued for life because it does not lead to the full eradication of infection. HIV persists in resting CD4(+) T cells, and possibly other cell types, and can reemerge from these cells when therapy is interrupted. Here, we review molecular mechanisms that have been proposed to contribute to HIV latency, as well as the relative roles of cis- and trans-acting mechanisms. We also discuss existing and future therapeutic opportunities regarding HIV latency that might lead to a future cure for HIV infection.

Citing Articles

The Proviral Reservoirs of Human Immunodeficiency Virus (HIV) Infection.

Murzin A, Elfimov K, Gashnikova N Pathogens. 2025; 14(1).

PMID: 39860976 PMC: 11768375. DOI: 10.3390/pathogens14010015.

Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches.

Tarasova O, Petrou A, Ivanov S, Geronikaki A, Poroikov V Int J Mol Sci. 2024; 25(17).

PMID: 39273355 PMC: 11395507. DOI: 10.3390/ijms25179408.

Pembrolizumab in an HIV-infected patient with glioblastoma.

Yuen C, Bao S, Pekmezci M, Mo F, Kong X Immunotherapy. 2024; 16(12):803-811.

PMID: 38889068 PMC: 11457652. DOI: 10.1080/1750743X.2024.2362566.

Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.

Wilhelm E, Poirier M, Da Rocha M, Bedard M, McDonald P, Lavigne P PLoS Pathog. 2024; 20(5):e1011821.

PMID: 38781120 PMC: 11115230. DOI: 10.1371/journal.ppat.1011821.

HIV-Tocky system to visualize proviral expression dynamics.

Reda O, Monde K, Sugata K, Rahman A, Sakhor W, Rajib S Commun Biol. 2024; 7(1):344.

PMID: 38509308 PMC: 10954732. DOI: 10.1038/s42003-024-06025-8.

References

Xing S, Siliciano R . Targeting HIV latency: pharmacologic strategies toward eradication. Drug Discov Today. 2012; 18(11-12):541-51. PMC: 3672351. DOI: 10.1016/j.drudis.2012.12.008. View

Han Y, Lin Y, An W, Xu J, Yang H, OConnell K . Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe. 2008; 4(2):134-46. PMC: 2604135. DOI: 10.1016/j.chom.2008.06.008. View

Stadeli K, Richman D . Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther. 2012; 18(1):115-23. PMC: 4295493. DOI: 10.3851/IMP2437. View

Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

Yang H, Xing S, Shan L, OConnell K, Dinoso J, Shen A . Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest. 2009; 119(11):3473-86. PMC: 2769176. DOI: 10.1172/JCI39199. View

Said E, Dupuy F, Trautmann L, Zhang Y, Shi Y, El-Far M . Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med. 2010; 16(4):452-9. PMC: 4229134. DOI: 10.1038/nm.2106. View

Sahu G, Lee K, Ji J, Braciale V, Baron S, Cloyd M . A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. Virology. 2006; 355(2):127-37. DOI: 10.1016/j.virol.2006.07.020. View

Baldauf H, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M . SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012; 18(11):1682-7. PMC: 3828732. DOI: 10.1038/nm.2964. View

Lewinski M, Bisgrove D, Shinn P, Chen H, Hoffmann C, Hannenhalli S . Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol. 2005; 79(11):6610-9. PMC: 1112149. DOI: 10.1128/JVI.79.11.6610-6619.2005. View

10.

Li M, Sanjabi S, Flavell R . Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006; 25(3):455-71. DOI: 10.1016/j.immuni.2006.07.011. View

11.

Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos C, Quigley M . A human memory T cell subset with stem cell-like properties. Nat Med. 2011; 17(10):1290-7. PMC: 3192229. DOI: 10.1038/nm.2446. View

12.

Ritland Politz J, Scalzo D, Groudine M . Something silent this way forms: the functional organization of the repressive nuclear compartment. Annu Rev Cell Dev Biol. 2013; 29:241-70. PMC: 3999972. DOI: 10.1146/annurev-cellbio-101512-122317. View

13.

Anderson I, Low J, Weston S, Weinberger M, Zhyvoloup A, Labokha A . Heat shock protein 90 controls HIV-1 reactivation from latency. Proc Natl Acad Sci U S A. 2014; 111(15):E1528-37. PMC: 3992654. DOI: 10.1073/pnas.1320178111. View

14.

Bullen C, Laird G, Durand C, Siliciano J, Siliciano R . New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med. 2014; 20(4):425-9. PMC: 3981911. DOI: 10.1038/nm.3489. View

15.

Jern P, Coffin J . Effects of retroviruses on host genome function. Annu Rev Genet. 2008; 42:709-32. DOI: 10.1146/annurev.genet.42.110807.091501. View

16.

Jordan A, Defechereux P, Verdin E . The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 2001; 20(7):1726-38. PMC: 145503. DOI: 10.1093/emboj/20.7.1726. View

17.

Farber D, Yudanin N, Restifo N . Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2013; 14(1):24-35. PMC: 4032067. DOI: 10.1038/nri3567. View

18.

van der Sluis R, van Montfort T, Pollakis G, Sanders R, Speijer D, Berkhout B . Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes. PLoS Pathog. 2013; 9(3):e1003259. PMC: 3605277. DOI: 10.1371/journal.ppat.1003259. View

19.

Shan L, Yang H, Rabi S, Bravo H, Shroff N, Irizarry R . Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model. J Virol. 2011; 85(11):5384-93. PMC: 3094997. DOI: 10.1128/JVI.02536-10. View

20.

Deeks S . HIV: Shock and kill. Nature. 2012; 487(7408):439-40. DOI: 10.1038/487439a. View